What is the current Price Target for the Leap Therapeutics, Inc. stock?

The average Leap Therapeutics, Inc. target price is $3.06. This is 554.41% higher than the current stock price. The highest price target is 573.65%, the lowest is 547.99%. 3 Analysts have issued a price target Leap Therapeutics, Inc. 2026 .

How high will the Leap Therapeutics, Inc. stock rise?

No reliable answer can be given as to how high the Leap Therapeutics, Inc. stock will rise. The performance of stocks, including the Leap Therapeutics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Leap Therapeutics, Inc. stock today?

The performance of Leap Therapeutics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Leap Therapeutics, Inc. stock fall?

The decline in Leap Therapeutics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Leap Therapeutics, Inc. Forecast, price target & analysts

$0.47

1.78% yesterday

Nasdaq, Oct 23, 10:17 pm CET

ISIN

US52187K1016

Symbol

LPTX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Leap Therapeutics, Inc. Target price 2025 - Analyst rating & recommendation

Leap Therapeutics, Inc. Classifications & Recommendation:

Hold

50%

Sell

50%

Leap Therapeutics, Inc. Price Target

Target Price	$3.06
Price	$0.47
Potential	554.41% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Leap Therapeutics, Inc. 2026 . The average Leap Therapeutics, Inc. target price is $3.06. This is 554.41% register free of charge higher than the current stock price. The highest price target is $3.15 573.65% register free of charge , the lowest is $3.03 547.99% register free of charge .
	A rating was issued by 6 analysts: 0 Analysts recommend Leap Therapeutics, Inc. to buy, 3 to hold and 3 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Leap Therapeutics, Inc. stock has an average upside potential 2026 of 554.41% register free of charge . Most analysts recommend the Leap Therapeutics, Inc. stock at Sell or hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.81	-1.13
	54.52%	37.57%
P/E		negative

3 Analysts have issued a Leap Therapeutics, Inc. forecast for earnings per share. The average Leap Therapeutics, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.81	54.52%
2025	$-1.13 37.57% Unlock
2026	$-0.54 52.21% Unlock
2027	$-0.56 3.70% Unlock
2028	$-0.64 14.29% Unlock
2029	$-0.23 64.06% Unlock
2030	$0.06 126.09% Unlock
2031	$0.37 516.67% Unlock
2032	$0.62 67.57% Unlock

Current	-0.29	82.74%
2025	-0.41 39.41% Unlock
2026	-0.86 109.76% Unlock
2027	-0.83 3.49% Unlock
2028	-0.73 12.05% Unlock
2029	-1.99 172.60% Unlock
2030	7.64 483.92% Unlock
2031	1.27 83.38% Unlock
2032	0.75 40.94% Unlock

Leap Therapeutics, Inc....

Current Leap Therapeutics, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 27 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 29 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 16 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 15 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 27 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 29 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 16 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 15 2024

Discover more stocks with a high price target

TUI 51.95%

BioNTech SE - ADR 33.40%

Deutsche Telekom 32.24%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now